Digicann Ventures Inc (AGFAF)
0.0179
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Digicann Ventures Total Assets (Quarterly): 0.5572M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.5572M |
September 30, 2023 | 2.275M |
June 30, 2023 | 2.093M |
March 31, 2023 | 0.6747M |
December 31, 2022 | 0.8066M |
September 30, 2022 | 27.38M |
June 30, 2022 | 31.19M |
March 31, 2022 | 35.12M |
December 31, 2021 | 36.25M |
September 30, 2021 | 37.38M |
June 30, 2021 | 40.10M |
March 31, 2021 | 50.46M |
December 31, 2020 | 48.41M |
September 30, 2020 | 103.70M |
June 30, 2020 | 102.51M |
March 31, 2020 | 96.70M |
December 31, 2019 | 82.38M |
September 30, 2019 | 122.88M |
June 30, 2019 | 45.92M |
March 31, 2019 | 38.21M |
December 31, 2018 | 22.02M |
September 30, 2018 | 6.380M |
June 30, 2018 | 6.911M |
March 31, 2018 | 6.659M |
December 31, 2017 | 7.218M |
Date | Value |
---|---|
September 30, 2017 | 3.248M |
June 30, 2017 | 3.004M |
March 31, 2017 | 2.769M |
December 31, 2016 | 1.279M |
September 30, 2016 | 1.623M |
June 30, 2016 | 1.476M |
March 31, 2016 | 1.526M |
December 31, 2015 | 2.558M |
September 30, 2015 | 2.259M |
June 30, 2015 | 2.620M |
March 31, 2015 | 0.7772M |
December 31, 2014 | 0.6133M |
September 30, 2014 | 0.7714M |
June 30, 2014 | 0.3739M |
March 31, 2014 | 0.4592M |
December 31, 2013 | 0.2474M |
September 30, 2013 | 1.743M |
June 30, 2013 | 1.762M |
March 31, 2013 | 1.834M |
December 31, 2012 | 1.930M |
September 30, 2012 | 1.865M |
June 30, 2012 | 1.791M |
March 31, 2012 | 1.889M |
December 31, 2011 | 1.869M |
September 30, 2011 | 1.381M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.5572M
Minimum
Dec 2023
122.88M
Maximum
Sep 2019
45.62M
Average
37.38M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 6.475M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.025M |
Shareholders Equity (Quarterly) | -0.3697M |
Debt to Equity Ratio | -2.344 |
Current Ratio | 0.5437 |
Net Debt Paydown Yield | 999.3% |